|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Echovirus IgA ELISA | Bevacizumab (Avastin®) ELISA | Complement System Classical Pathway ELISA Assay | Mumps Virus IgM ELISA | Neopterin ELISA Assay |
| Catalog Number | IB05048 | TM09010 | COMPL CP310 RUO | IB79883 | IB79188 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of human IgA antibodies directed against ECHO viruses in serum or plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Bevacizumab (Avastin®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The Wieslab® COMPL CP310 is an enzyme immunoassay (ELISA) for the determination of functional classical complement pathway in human serum. For research use only, not for use in diagnostic procedures. | The Mumps Virus IgM ELISA is intended for the determination of IgM class antibodies against Mumps Virus in human serum or plasma (citrate, heparin). For research use only - not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of Neopterin in human serum, plasma and urine. For research use only, not for use in diagnostic procedures. |
| Detection Target | Echovirus IgA | Bevacizumab (Avastin®) | Human Phopsho Tau (217P) | Soluble Leptin Receptor (sLEP-R) | Endothelial Lipase (EL) C-Terminal |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Serum and plasma. | Cerebrospinal fluids | Serum or plasma | Human serum and EDTA plasma. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 0 / 6 to 200 ng/mL | Inquire | A cut-off control is used for the interpretation of results. | 1.35 to 111 nmol/L |
| Sensitivity | > 95% | 2 ng/mL | 8.07 pg/mL | 0.0385 ng/mL | 0.01 ng/mL |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | 1 hour, 45 min. total incubation time. | 2 hrs (incubation) | 1 hr 45 mins (incubation) | 1 hr 40 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |